D.E. Shaw & Co’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-42,684
Closed -$2.38M 4123
2018
Q4
$2.38M Sell
42,684
-148,421
-78% -$8.06M ﹤0.01% 2012
2018
Q3
$8.88M Sell
191,105
-111,905
-37% -$5.42M 0.01% 1189
2018
Q2
$14.6M Sell
303,010
-19,807
-6% -$948K 0.02% 889
2018
Q1
$14M Buy
322,817
+71,460
+28% +$3.21M 0.02% 822
2017
Q4
$9.98M Sell
251,357
-22,837
-8% -$952K 0.01% 1028
2017
Q3
$11.9M Buy
274,194
+65,407
+31% +$2.98M 0.02% 840
2017
Q2
$9.99M Buy
208,787
+11,781
+6% +$549K 0.02% 897
2017
Q1
$8.09M Buy
197,006
+5,189
+3% +$217K 0.01% 993
2016
Q4
$7.37M Buy
191,817
+128,922
+205% +$5.24M 0.01% 1118
2016
Q3
$3.38M Buy
62,895
+34,878
+124% +$1.62M 0.01% 1551
2016
Q2
$1.21M Buy
+28,017
New +$1.18M ﹤0.01% 2293
2016
Q1
Sell
-5,333
Closed -$338K 3959
2015
Q4
$338K Buy
+5,333
New +$363K ﹤0.01% 3312
2015
Q3
Sell
-223,900
Closed -$15.2M 4022
2015
Q2
$15.2M Buy
223,900
+78,608
+54% +$4.34M 0.02% 756
2015
Q1
$6.2M Buy
145,292
+100,218
+222% +$4.46M 0.01% 1244
2014
Q4
$2.23M Buy
+45,074
New +$1.8M ﹤0.01% 2187
2014
Q3
Sell
-14,450
Closed -$378K 4551
2014
Q2
$378K Buy
14,450
+8,675
+150% +$224K ﹤0.01% 3715
2014
Q1
$322K Sell
5,775
-5,311
-48% -$306K ﹤0.01% 3874
2013
Q4
$534K Sell
11,086
-24,405
-69% -$1.03M ﹤0.01% 3689
2013
Q3
$1.49M Sell
35,491
-32,360
-48% -$1.54M ﹤0.01% 2682
2013
Q2
$3.06M Buy
+67,851
New +$2.66M 0.01% 1727

D.E. Shaw & Co's IMPV Position: Q1 2019 in Review

D.E. Shaw & Co sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 42,684 shares — an estimated $2.38M sold.

D.E. Shaw & Co first reported a position in IMPV in Q2 2013 and held it in 20 quarters. The position peaked at $15.2M in Q2 2015. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • D.E. Shaw & Co reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 42,684 Imperva, Inc. shares in Q1 2019, an estimated $2.38M.
  • D.E. Shaw & Co first reported a position in Imperva, Inc. in Q2 2013 and held it in 20 quarters.
  • D.E. Shaw & Co's Imperva, Inc. position peaked at $15.2M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.